RecruitingNCT07530497

Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures


Sponsor

SI-BONE, Inc.

Enrollment

120 participants

Start Date

Aug 1, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to evaluate outcomes in patients treated with iFuse TORQ TNT for pelvic fragility fractures.


Eligibility

Min Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called iFuse TORQ TNT Implant System for people with fracture; pelvic, fragility fracture, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 60 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEiFuse TORQ TNT Implant System

FDA-clear implant used for fracture fixation of the pelvis, including acute, non-acute, and non-traumatic fractures and sacroiliac joint fusion for sacroiliac joint dysfunction including sacroiliac joint disruption and degenerative sacroiliitis.


Locations(2)

Mayo Clinic

Rochester, Minnesota, United States

Orthopaedic Associates of Reading

Wyomissing, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07530497


Related Trials